Why did you participate in the Biomapas Academy?
Everything started when I had a trip to a career fair during my studies. This was the first time I met Biomapas in person as there were several lecturers that presented the company itself and its activities. I remember thinking that I would like to work with this team as it piqued my interest.
Later, when I was working on my master’s degree, I came across an advertisement on social media for the Biomapas Academy. I already knew that I wanted to learn more about the pharma industry and was interested in various opportunities, so I applied for this opportunity.
How was your experience during the three months?
The Academy was a continuous cycle spanning several months of interesting lectures from true professionals with extensive knowledge. During this short time, I learned a lot about product development, research, safety information and its systems, different possible roles and their responsibilities, and new opportunities where young specialists can grow and find their place in the life sciences industry.
What did the future hold for you after the Academy?
A while after the Academy, I officially became part of Biomapas and its big family! With my background being an MPharm, I was always interested in drug safety. Therefore, I am working in the Pharmacovigilance Department as a Pharmacovigilance Project Management Assistant. I must say there are many interesting things to learn and experience that I am looking forward to with my team.
What would you say to the future participants?
If you are thinking about participating in the Academy, do not hesitate. Being an alumnus, I can say that you will definitely see the pharma industry from within. It will broaden your understanding; you will gain needed knowledge and experience in life sciences and will be able to apply that information working in your chosen field. I hope to see you at Biomapas!
Biomapas Academy
What is Clinical Research? Regulatory Affairs? Pharmacovigilance?
When Do Biotech Companies and Startups Need Pharmacovigilance
Many biotech startups assume pharmacovigilance begins after approval, but regulatory expectations and clinical trial complexity often require safety oversight much earlier. Learn when pharmacovigilance becomes essential and how to stay compliant as you scale.
How to Build Clinical Safety for Biotechs Without a Full Department
Discover how biotech companies can build scalable clinical safety management early, ensuring compliance, oversight, and efficient operations across development phases.
Biomapas Insights: Navigating Italian Regulatory Requirements and AIFA Updates
Clear guidance on Italian regulatory requirements for promotional materials and recent AIFA updates affecting pharmaceutical companies.
Clinical Safety Management in Pharma: How to Manage Risk Across the Drug Development Lifecycle
Learn how effective clinical trial safety management supports risk mitigation, regulatory compliance, and patient safety across all stages of drug development.
Global Case Processing in Pharmacovigilance: Practical Guide to Compliance, Quality, and Scale
As pharmacovigilance expands across markets, maintaining control becomes challenging. In this article, we explore key risks, regulatory differences, and scalable models for global case processing.
Case Study: International & Local Pharmacovigilance/Medical Information Services – Urgent Action
Discover how Biomapas delivered a seamless global and local transition for a pharmaceutical company, facing a critical Pharmacovigilance and Medical Information vendor transition with a non‑negotiable one‑month timeline.
Marketing Pharmaceutical Products in CIS/Eurasian Economic Union
Explore how pharmaceutical companies can successfully market products in CIS and EAEU countries, highlighting regulatory differences from the EU, recent legislative changes, and practical RA and pharmacovigilance considerations.
Partial Pharmacovigilance Outsourcing: A Scalable Approach for Biopharma
Learn how partial pharmacovigilance outsourcing helps biopharma maintain oversight while scaling resources effectively.
Pharmacovigilance and Medical Information Outsourcing: Benefits for Biotech
Learn how PV and MI outsourcing enables biotechs to reduce costs, scale efficiently, strengthen compliance, and accelerate market readiness.
Biomapas Insights: Clinical Site Selection for Early Phase Oncology Studies
Expert perspectives on where to begin, how to choose the right clinical sites, and what to consider when selecting an eCRF/EDC system for early-phase oncology studies.
